| Literature DB >> 26037906 |
Olugbenga Oguntunde1,2, Zulfiya Charyeva3, Molly Cannon4, William Sambisa5,6, Nosakhare Orobaton7,8, Ibrahim A Kabo9, Kamil Shoretire10, Saba'atu E Danladi11, Nurudeen Lawal12, Habib Sadauki13.
Abstract
BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO4) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26037906 PMCID: PMC4451740 DOI: 10.1186/s12884-015-0554-8
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Data collection methods, respondents and thematic areas
| Data Collection Instrument | Respondents | Thematic area |
|---|---|---|
| Quantitative | ||
| SP questionnaire | 80 SPs, 40 in each state | To obtain information on knowledge of PE/E and its management as well as current practices about PE/E management in the health facilities |
| Observational checklist | 80 facilities, 40 in each state | To assess the infrastructure and equipment that are available for management of PE/E at the health facilities; |
| Qualitative | ||
| In-depth interviews with facility managers | 30, 15 in each state | To obtain information from the managers of the health facilities in order to explore individual, organizational and community factors that are associated with the use of magnesium sulphate in the management of PE/E in the health facilities |
Characteristics of study participants and health facilities
| Characteristic | % |
|---|---|
|
| |
| CHEWs | 55 |
| Nurse Midwife | 40 |
| CHO | 4 |
| Environmental Health Assistant | 1.3 |
|
| |
| Nurse/Midwife | 53.3 |
| CHEW | 40 |
| CHO | 6.7 |
|
| |
| General Hospitals | 25 |
| Primary Health Centers (PHC) | 50 |
| MCHa | 25 |
aFacilities render mainly maternal and child health services unlike PHCs that provide complete set of primary health care services
Facilitators and barriers to the management of PE/E using MgSO4 by type of facility
| Item | Hospitals (n = 20), % | Health centers (n = 60), % | Total (n = 80), % |
|---|---|---|---|
|
| |||
| Attendance of a training on PE/E by SP | 60 | 38.3 | 43.8 |
| Identification of MgSO4 as first line drug by SP† | 85 | 58 | 65 |
| Availability of service registers in the facility | 80 | 58.3 | 63.7 |
|
| |||
| Non-availability of MgSO4 | |||
| Reported by SP † | 15 | 46.7 | 38.8 |
| Facility inventory | 35 | 63.4 | 56.2 |
| MgSO4 stockout§ in the facilitya | 46 | 33 | 40 |
| Non-availability of clinical guidelines/protocols in the facility† | 50 | 90 | 80 |
| No supportive supervision¶ received by SP † | 55 | 90 | 81.2 |
aAmong those that had MgSO4 on the day of survey, N = 35
† p-value < 0.05
§Events where supplies were completely exhausted before re-supply
¶Routine supervisory visits by States’ Ministry of Health officials during which service providers are mentored and provided with technical assistance to improve on their work